Literature DB >> 23321992

A Trich-y question: should Trichomonas vaginalis infection be reportable?

Brooke E Hoots1, Thomas A Peterman, Elizabeth A Torrone, Hillard Weinstock, Elissa Meites, Gail A Bolan.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23321992      PMCID： PMC5024551          DOI： 10.1097/OLQ.0b013e31827c08c3

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  28 in total

1.  Incidence of Trichomonas vaginalis in marital partners.

Authors:  L WATT; R F JENNISON
Journal:  Br J Vener Dis       Date:  1960-09

2.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

3.  Planning a public health surveillance system.

Authors:  S M Teutsch; S B Thacker
Journal:  Epidemiol Bull       Date:  1995-03

4.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

5.  Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group.

Authors:  T A Peterman; L S Lin; D R Newman; M L Kamb; G Bolan; J Zenilman; J M Douglas; J Rogers; C K Malotte
Journal:  Sex Transm Dis       Date:  2000-09       Impact factor: 2.830

6.  The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.

Authors:  D Heather Watts; Gayle Springer; Howard Minkoff; Sharon L Hillier; Lisa Jacobson; Michael Moxley; Jessica Justman; Helen Cejtin; Casey O'Connell; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

7.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

8.  High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

Authors:  Jane R Schwebke; Edward W Hook
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

9.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

10.  Natural history of urogenital trichomoniasis in men.

Authors:  J N Krieger; M Verdon; N Siegel; K K Holmes
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450
View more
  17 in total

Review 1.  Mycoplasma genitalium and Trichomonas vaginalis: addressing disparities and promoting public health control of two emerging sexually transmitted infections.

Authors:  Faye Korich; Neha G Reddy; Maria Trent
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Response to "Implications of Trichomonas vaginalis nucleic acid amplification testing on medical training and practice".

Authors:  C C Ginocchio; K Chapin; J S Smith; J Snook; C S Hill; J Aslanzadeh; C A Gaydos
Journal:  J Clin Microbiol       Date:  2013-05       Impact factor: 5.948

4.  Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.

Authors:  Elissa Meites; Eloisa Llata; Jim Braxton; Jane R Schwebke; Kyle T Bernstein; Preeti Pathela; Lenore E Asbel; Roxanne P Kerani; Christie J Mettenbrink; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

Review 5.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

6.  Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?

Authors:  Christina A Muzny
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

7.  Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system.

Authors:  Barbara Van Der Pol; James A Williams; Stephanie N Taylor; Catherine L Cammarata; Charles A Rivers; Barbara A Body; Melinda Nye; Deanna Fuller; Jane R Schwebke; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

8.  Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?

Authors:  Christina A Muzny; Saralyn Richter; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

9.  Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States.

Authors:  Eshan U Patel; Charlotte A Gaydos; Zoe R Packman; Thomas C Quinn; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 10.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.